Introduction
============

The Montreal consensus conference defined gastroesophageal reflux disease (GERD), as "a condition which develops when the reflux of gastric contents causes troublesome symptoms and/or complications" \[[@b1-cm-93-145]\].

Typical symptoms of GERD are heartburn and acid regurgitation but, in many patients, other digestive symptoms are found, like belching, sialorrhea or sore throat. Other important reflux symptoms include extraesophageal manifestations: pulmonary complications: asthma, chronic cough, ENT manifestations: dysphonia, laryngitis, ulcer and laryngeal polyps, sinusitis, otitis, or non-cardiac chest pain. Still, the most seen GERD complications remain reflux esophagitis and Barrett's esophagus \[[@b2-cm-93-145]\].

The pathogenesis of GERD is multifactorial. The most important factors include transient lower esophageal sphincter relaxation, high intraabdominal pressure, reduced esophageal capacitance, low gastric compliance, delayed gastric emptying and impaired esophageal clearance. Gastric juice includes ingested food and drink, acid and digestive enzyme of which the most important is pepsin. All these components can be refluxed from the stomach into the esophagus, larynx and respiratory system. Pepsin, the enzyme responsible for the crude digestion of protein is the main aggressive agent responsible for damaging esophageal and laryngeal tissue during reflux \[[@b3-cm-93-145]--[@b6-cm-93-145]\].

Thus the detection of pepsin in the refluxate is an appropriate objective clinical measurement tool, because it specifically detects the damaging component of gastric refluxate.

Peptest™ is the world's first non-invasive diagnostic test for reflux disease. The Peptest kit is an immunological in-vitro diagnostic medical device that contains two pepsin monoclonal antibodies; it allows you to identify pepsin in a clinical sample of saliva/sputum quickly and easily. This test permits pH independent identification of patients suffering from gastric reflux. It detects pepsin, with a detection limit of 16 ng/ml in clinical samples obtained from the upper digestive tract and the respiratory system. The presence of pepsin in these samples is a reliable marker for the reflux of gastric juice. An important aspect is that PPI medication does not influence the test result \[[@b7-cm-93-145]\].

The studies conducted on salivary Peptest regarding it's efficacy in diagnosing GERD and extraesophageal manifestation revealed encouraging results \[[@b8-cm-93-145]--[@b13-cm-93-145]\]. Peptest also yielded good results as it respects the diagnosis of extraesophageal reflux in children with chronic otitis media with effusions, a category of patients in whom invasive investigations are much more difficult to perform \[[@b14-cm-93-145],[@b15-cm-93-145]\].

A study performed in 2019 on more than one thousand patients revealed that the sensitivity of Peptest was high, but the specificity moderate in GERD diagnosis \[[@b16-cm-93-145]\]. Others works showed that patients with extraesophageal manifestations of GERD like asthma had higher values of salivary pepsin than controls \[[@b17-cm-93-145]\].

Other two studies revealed that salivary Peptest could be a good tool for laryngopharyngeal reflux diagnosis in symptomatic and asymptomatic patients \[[@b18-cm-93-145],[@b19-cm-93-145]\]. In 2019 Klimara et al. demonstrated that there was a correlation between high salivary pepsin values, and patients with multichannel intraluminal impedance-pH (MII-pH) demonstrated laringopharyngeal reflux \[[@b20-cm-93-145]\]. It seems that patients with obstructive sleep apnea present positive tests for salivary pepsin \[[@b21-cm-93-145]\].

A special class of patients affected by gastric reflux are opera singers. They perform singing tasks that require rapid changes of subglottal pressure with consistent use of the diaphragm, which causes an abrupt and prolonged increase in intra-abdominal pressure, deep inspiration, and straining. Because the diaphragmatic sphincter is disabled by these mechanisms, repeated over many years of professional activity, the occurrence of reflux symptoms is increased. Opera singers may be at risk to develop GERD because of their effort to sing.

There are several studies regarding this topic who showed that professional opera singers have a statistically significantly higher prevalence of GERD symptoms than control \[[@b22-cm-93-145]--[@b25-cm-93-145]\]. All these studies were performed using scores from different questionnaires related to symptomatology, but no biological test was performed.

Objective
=========

The purpose of our study was to evaluate GERD in vocal opera students and to compare this aspect with the prevalence of gastresophageal reflux in medical students and residents.

We used a totally noninvasive test, the salivary Peptest, in order to avoid any annoying esophageal catheterization during pH-monitoring.

Methods
=======

Subjects
--------

The study included 30 of 35 vocal opera students from the Music Academy of the city of Cluj-Napoca, Romania, enrolled in the "canto" section. The inclusion criteria were: students from "canto" section, who signed the informed consent, with the age between 19--60 years. The exclusion criteria were: other associated diseases which could produce a gastroesophageal reflux (current gastritis or gastric ulcer, history of gastric or biliary surgery, liver and renal pathology, allergies, respiratory or ENT diseases), 48 hours prior administration of antacids (like Gaviscon for example) and subjects who did not want to take part in the study.

As controls, 20 medical students and residents with a similar distribution of age and sex were recruited.

A symptom evaluation was made, using questionnaires regarding heartburn, cough, epigastric pain, hoarseness and nausea.

Protocol
--------

This is a prospective, case-control study, undertaken in a single center. All participants filled a demographic questionnaire which was self-completed including socio-demographic data, medical history, lifestyle and symptoms.

Our study was approved by the the Ethics Committee of the Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca Romania. The number of the approval is 526 from 09.02.2016.

After obtaining informed consent, a saliva sample was taken, a minimum of 1 ml into a 30 ml universal sample collection tube containing citric acid to preserve the action of any pepsin present. Each participant took one sample of saliva at least one hour after the meal. All the samples were stored in a refrigeratos according to manufacturer's recommendations and were processed within less than seven days after saliva collection.

The collection tube were centrifuged at 4000 rpm for 5 minutes. From the clear supernatant layer a 80 μl was taken and transferred into a microtube containing 240 μ of migration buffer solution. Those samples were mixed with a vortex mixer for 10 seconds. After that, from the last samples using a pipette was applied the same volume on the circular well of the Peptest lateral flow device (RD Biomed Ltd., Hull, UK). After it was confirmed that the test was working correctly, meaning a blue line appeared below the "C" letter on the device, the Peptes kit results were read in the first 15 minutes. A second blue line below the "T" letter on the device meant a positive result. This study was approved by the ethical committee of the Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca.

Statistics
----------

Data were entered into a computer using the program R version 3.2.1 (2015-06-18) and analyzed by chi-square and Fischer's test. The prevalence of positive salivary test in both groups was calculated. A P-value\<0.05 was considered significant.

Results
=======

Demographic data
----------------

In this study 30 vocal opera students were recruited. As controls were enrolled 20 medical students and residents. As shown in [Table I](#tI-cm-93-145){ref-type="table"} the mean age in the vocal opera group was 23 and in the control group 27. In the vocal opera students group 12 (40%) were male and 18 (60%) were female. In the control group 7 (35%) were male and 13 (65%) were female. According to [Table II](#tII-cm-93-145){ref-type="table"}, from 30 vocal opera students only 15 (50%) reported reflux symptoms, (P\<0.001) of which the main symptoms were heartburn and hoarseness (see [Figure 1](#f1-cm-93-145){ref-type="fig"}). Peptest was positive in 96.67% cases (29 from 30) in vocal opera students group versus 30% (6 from 20), in the control group P\<0.001.

According to the data of the study a vocal opera student presents the probability of 3.22 (95% confidence interval, CI 1.64 -- 6.31) of having a positive Peptest compared to the general population.

Discussion
==========

The aim of the study was to evaluate gastroesophageal reflux in vocal opera students using salivary Peptest. This is the first medical study in which GERD is assessed in this professional category by using a biological diagnostic test. The results of the study showed that although only half of those included in the study group reported reflux symptoms, almost all of them had a positive salivary test. Vocal opera students presented not only GERD symptoms, but also items of dyspepsia; 26% of the symptomatic one accused epigastric pain and 20% nausea.

It should be noted that there is a wide age range in both groups, because each studied group had 1 subject who exceeded by far the average age.

An important aspect would be the fact that episodes of reflux are maintained by vocal performance, so the persistence of the symptomatology in these patients is a risk factor for the onset of chronic reflux laryngitis or its aggravation, a fact that may compromise the continuation of artistic careers of professional singers by negatively interfering with their professional performances. Camarota et al. reported clinical cases in which opera singers complained of worsening of the disease symptomatology during performing singing tasks with the ineffectiveness of administering antacid therapy \[[@b26-cm-93-145]\]. Yet, the results of our study were based on singers who are only at the beginning of their career.

The laryngeal examination made on 96 professional voice users (in which were included also opera singers) revealed a high prevalence of changes in the true vocal cords, false vocal cords and laryngeal mucosa in general \[[@b27-cm-93-145]\]. The mucosal exposure to acid and pepsin leads to numerous macroscopic and microscopic histopathological changes in the mucosa of the vibratory margin of the vocal folds, modifications which are responsible for the hoarseness, thus producing the impairment of the subjective and objective voice quality \[[@b28-cm-93-145]\].

We might conclude that gastroesophageal reflux affects a large percentage of the vocal opera students, this condition being occupation related, even if they have not performed for a long time. This fact raises the question if opera singers should be followed in time for severe chronic reflux complications, especially for esophagitis, Barrett's esophagus, adenocarcinoma and also, very important, laryngeal cancer. A study performed in 2015 on 30 patients with T1 laryngeal carcinoma has demonstrated that in these subjects there are significantly higher levels of laryngeal reflux disease components in the saliva (high level of bile acids, the total pepsin and the pepsin enzymatic activity) \[[@b29-cm-93-145]\], so there is a clear link between laryngeal reflux and the malignant pathology. What would be the right conduct in terms of preventing these complications and altering voice quality in these patients?

Another aspect should be mentioned, namely that adolescents are more likely to have a higher prevalence of gastroesophageal reflux, which could increase the number of positive tests in this case. There are 3 studies in the medical literature that demonstrates this \[[@b30-cm-93-145]--[@b32-cm-93-145]\].

Although it is a known fact that opera singers have a low compliance in terms of performing invasive diagnostic maneuvers for GERD for fear of having their vocal cords harmed, we have not found any data in the medical research regarding the refusal of esophageal intubation or catheterization in these patients and we also did not evaluate this aspect in our study.

The present study has its limitations given that it was performed on a small number of patients and it was also not possible to perform pH-metry or superior digestive endoscopy to compare the results obtained from salivary tests. Further studies are needed.

Conclusions
===========

Vocal opera students are at high risk of developing gastroesophageal reflux. Non-invasive salivary Peptest could be a useful tool in diagnosing GERD in these patients. However, this fact has to be confirmed by further studies.
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###### 

Demographic characteristics and lifestyle in study groups.

  --------------------------------------------------------------------------------------------------
  Group                              Control (n=20)        Vocal opera students (n=30)   p-value
  ---------------------------------- --------------------- ----------------------------- -----------
  Gender (m), n (%)                  7 (35)                12 (40)                       0.721

  Age (years), median (IQR)          27 (23.75 -- 28.25)   23 (20--24)                   **0.002**

  Place of residence (urban), n(%)   14 (70)               25 (83.33)                    0.311

  Smoking, n(%)                      2 (10)                3 (10)                        1

  Alcohol, n (%)                     every day: 1 (5)\     every day: 1 (3.33)\          
                                     no: 8 (40)\           no: 14 (46.67)\               
                                     occasional: 11 (55)   occasional: 15 (50)           
  --------------------------------------------------------------------------------------------------

###### 

Reflux symptoms and Peptest results in study groups.

  Group                        Controls (n=20)   Vocal opera students (n=30)   p-value
  ---------------------------- ----------------- ----------------------------- -------------
  Reflux symptoms, n(%)        0 (0)             15 (50)                       **\<0.001**
  Peptest (positive ), n (%)   6 (30)            29 (96.67)                    **\<0.001**
